FDA To Create Two Lists Of Customers of Tainted Steroids
The Food & Drug Administration announced today its intention to create two new lists of the customers who received the contaminated steroids sold by New England Compounding Center. The first of these lists will include the names and addresses of the customers by state. The second list will include that data, as well as identifying the specific product shipped, the quantities shipped and the date shipped. Even so, the FDA says these lists are compiled from data supplied by NECC; therefore, the FDA cannot vouch for the completeness or accuracy of the information on the lists at this point. The FDA still recommends to health care providers that follow up with patients be done promptly under the following circumstances:
- The medication administered was an injectable NECC product, including an opthalmic drug injected or used in conjunction with eye surgery or a cardioplegic solution;
- The product was shipped by NECC on or after May 21, 2012;
- The product was administered to a patient on or after May 21, 2012.
Based on those three criteria, the FDA is urging health care providers to follow up with patient who are believed, based upon this updated shipping information, to be at the greatest risk of having been exposed to the contaminated steroid medications.
If you believe you were exposed to these contaminated steroid medications through orthopedic, opthalmic or cardioplegic steroid injections, contact CGWC for a free consultation. We already represent over 20 victims of this outbreak of fungal meningitis.